Charles Wagner

Mr. Charles F.
Wagner is a President & Director at Crinetics Pharmaceuticals, Inc., an Independent Director at The TJX Cos., Inc., an EVP, Chief Financial & Operating Officer at Vertex Pharmaceuticals, Inc. and a Chief Executive Officer at ViaCyte, Inc. He is on the Board of Directors at Crinetics Pharmaceuticals, Inc. and The TJX Cos., Inc. Mr. Wagner was previously employed as a Treasurer & Director by Alpine Immune Sciences, Inc., a Chief Financial Officer & Executive VP-Finance by Ortho-Clinical Diagnostics, Inc., a Chief Financial Officer & EVP-Administration by Progress Software Corp., a Chief Financial Officer & EVP-Administration by Bruker Corp., a Chief Financial Officer & Vice President by Millipore Corp., a Manager by Bain & Co., Inc., a Manager by Coopers & Lybrand LLP, and a Chief Financial Officer & Vice President by Merck Life Science AB. He also served on the board at Good Start Genetics, Inc. and Bruker Energy & Supercon Technologies, Inc. He received his undergraduate degree from Boston College and an MBA from Harvard Business School.